Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
57,572,193
-
Total 13F shares
-
59,101,687
-
Share change
-
-352,635
-
Total reported value
-
$1,935,404,930
-
Put/Call ratio
-
72%
-
Price per share
-
$32.75
-
Number of holders
-
289
-
Value change
-
-$15,482,554
-
Number of buys
-
141
-
Number of sells
-
128
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q1 2025
As of 31 Mar 2025,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by
289 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,101,687 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, MACQUARIE GROUP LTD, STATE STREET CORP, Stephens Investment Management Group LLC, RENAISSANCE TECHNOLOGIES LLC, LOOMIS SAYLES & CO L P, and GW&K Investment Management, LLC.
This page lists
289
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.